Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Made Scientific and Sentinel BioTherapeutics join forces to advance cell-therapy manufacturing program

Summary by BioProcess International
Made Scientific and Sentinel BioTherapeutics form strategic manufacturing partnership to advance SENT-001, an allogeneic encapsulated cell therapy for ovarian cancer, through Phase I/II clinical development at Made's Princeton facility.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

BioProcess InternationalBioProcess International

Made Scientific and Sentinel BioTherapeutics join forces to advance cell-therapy manufacturing program

Made Scientific and Sentinel BioTherapeutics form strategic manufacturing partnership to advance SENT-001, an allogeneic encapsulated cell therapy for ovarian cancer, through Phase I/II clinical development at Made's Princeton facility.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BioProcess International broke the news in on Wednesday, July 23, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Princeton, New Jersey icon

Princeton, New Jersey

You have read 1 out of your 5 free daily articles.

News
For You
SearchBlindspotLocal